Venture Capital & Emerging Companies
Viewpoints
Filter by:
Client Corner: Jerry Williamson, CEO of Sengenics
September 29, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products.
Read more
MintzTech Connect: All Things Technology — September 2023
September 12, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on mePrism
September 12, 2023 | Article | By Samuel Asher Effron
Mintz Venture Watch — Volume 5: A Report on Deal Trends from Q1 and Q2 2023
August 21, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Five Ways To Target Success As A Startup
July 11, 2023 | Article
Cross-border Considerations for the Life Sciences Industry
June 27, 2023 | Blog
Mintz welcomed investors and entrepreneurs from the Canadian and US life sciences ecosystem to our first annual matchmaking event in Toronto. In this video, hear about cross-border considerations for the sector and how Mintz’s life sciences focus positions us to guide emerging growth companies and investors doing business in both countries.
Read more
MintzTech Connect: All Things Technology — May 2023
May 24, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on Coefficient
May 24, 2023 | Article | By Daniel DeWolf
Benefits and Legal Risks of Embracing Generative AI Applications
April 5, 2023 | Blog | By Jeremy Glaser, Lorena Niebla
Generative artificial intelligence creates content and work efficiencies but also comes with legal pitfalls. Mintz Venture Capital & Emerging Companies Practice Co-chair Jeremy Glaser and Associate Lorena Niebla look at the technology's potential uses as well as risks related to data privacy, intellectual property, and more.
Read more
MintzTech Connect: All Things Technology — February 2023
February 21, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on Moolah Kicks
February 15, 2023 | Article | By Daniel DeWolf
Mintz Venture Watch — Volume 4: A Report on Deal Trends from 2022
February 9, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Extending for Success: The Rising Trend of Extension Rounds and the Importance of Due Diligence
January 11, 2023 | Article | By Jeremy Glaser, Roman M. Gorokhov, Will Perkins
MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022 | Article | By Daniel DeWolf
MintzTech Connect: All Things Technology — December 2022
December 7, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
OpEd: Top Five Ways to Accelerate Growth of Emerging Companies
October 21, 2022 | Blog
Mintz Leads For Axoft In $8 Million Seed Round Demonstrating Continued Dedication To Biotech Start-Up Market
October 19, 2022
Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology